Kura Oncology, Inc. (KURA)
12.40
+0.51
(+4.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.12
+0.72
(+5.81%)
After-Hours: 20:00
Kura Oncology 1 Year Total Returns (Daily) : 59.81% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 59.81% |
| August 20, 2026 | 66.10% |
| August 19, 2026 | 74.27% |
| August 18, 2026 | 64.84% |
| August 17, 2026 | 53.68% |
| August 14, 2026 | 64.55% |
| August 13, 2026 | 55.47% |
| August 12, 2026 | 60.32% |
| August 11, 2026 | 79.24% |
| August 10, 2026 | 77.80% |
| August 07, 2026 | 60.57% |
| August 06, 2026 | 53.90% |
| August 05, 2026 | 44.65% |
| August 04, 2026 | 49.84% |
| August 03, 2026 | 52.66% |
| July 31, 2026 | 48.93% |
| July 30, 2026 | 47.78% |
| July 29, 2026 | 40.19% |
| July 28, 2026 | 50.28% |
| July 27, 2026 | 62.92% |
| July 24, 2026 | 60.59% |
| July 23, 2026 | 62.27% |
| July 22, 2026 | 58.02% |
| July 21, 2026 | 68.32% |
| July 20, 2026 | 67.92% |
| Date | Value |
|---|---|
| July 17, 2026 | 64.55% |
| July 16, 2026 | 70.69% |
| July 15, 2026 | 84.83% |
| July 14, 2026 | 77.01% |
| July 13, 2026 | 73.73% |
| July 10, 2026 | 80.03% |
| July 09, 2026 | 96.10% |
| July 08, 2026 | 108.6% |
| July 07, 2026 | 111.1% |
| July 06, 2026 | 88.40% |
| July 02, 2026 | 91.05% |
| July 01, 2026 | 92.50% |
| June 30, 2026 | 90.12% |
| June 29, 2026 | 93.47% |
| June 26, 2026 | 90.23% |
| June 25, 2026 | 78.62% |
| June 24, 2026 | 77.59% |
| June 23, 2026 | 76.83% |
| June 22, 2026 | 77.09% |
| June 18, 2026 | 63.86% |
| June 17, 2026 | 54.35% |
| June 16, 2026 | 44.84% |
| June 15, 2026 | 48.14% |
| June 12, 2026 | 35.89% |
| June 11, 2026 | 28.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Inovio Pharmaceuticals, Inc. | -38.22% |
| Fortress Biotech, Inc. | 28.12% |
| Syndax Pharmaceuticals, Inc. | 24.05% |
| Spero Therapeutics, Inc. | -34.41% |
| Gossamer Bio, Inc. | -92.87% |